Skip to main content

Corcept Therapeutics Inc

CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001088856

In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Corcept Therapeutics Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CORT: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders1993202+6
Shares80.5M28.9K80.9M+390.4K (+0.5%)
Value$1.77B$636.0K$1.59B−$177.3M (−10.0%)

3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Corcept Therapeutics Inc at the end of Q3 2021 but not at the end of Q2 2021.

Sold out (21)

Institutions that held Corcept Therapeutics Inc at the end of Q2 2021 and filed for Q3 2021 without it.

Not filed for Q3 2021 yet (3)

Institutions that held Corcept Therapeutics Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CORT in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Smith Asset Management Group LP28,880$635.0K
CWM, LLC37$1.00K
First Horizon Corp14$0